A worldwide rise in immune and inflammatory diseases such as multiple sclerosis and inflammatory bowel diseases has been linked to Western society-based changes in lifestyle and environment. These include decreased … Continue Reading Sunlight affects the gut microbiota and vitamin D levels.
Existing in its own universe, controlling and caring for its host, the human gut contains trillions of bacteria, known as the microbiota, responsible for digesting food and regulating the immune … Continue Reading Gut microbiota protects against neurologic damage from viral infections.
Demyelinating diseases, such as multiple sclerosis and leukodystrophy, are characterized by damage to the protective myelin sheath that surrounds the axons of neurons. This demyelination can be caused by an … Continue Reading Cell therapy successfully promotes axon remyelination in an animal model.
Multiple myeloma, also known as myeloma, is a type of bone marrow cancer. Multiple myeloma affects the plasma cells, blood cell, inside the bone marrow. Myeloma does not take the form of a … Continue Reading Study is first to link multiple myeloma protein to extramedullary disease.
Multiple sclerosis (MS) is a neurodegenerative disease in which the immune system attacks the myelin that protects nerve fibers, upsetting the flow of information between the brain and the body. … Continue Reading Human study identifies the genetic cause of familial multiple sclerosis.
Multiple Sclerosis (MS) is a neurological disease, characterised by demyelination and the onset of chronic, neurodegenerative damage of the central nervous system. Right now, its causes are unknown although various … Continue Reading Researchers identify a new gene involved in Multiple Sclerosis.
Another year of growth for the Healthinnovations, many great breakthroughs, with previously immature technologies and disciplines coming into their own, as crucial parts of global innovation. For instance, biomarkers have … Continue Reading The Top Ten Healthinnovations of 2015.
An estimated 100,000 Canadians live with multiple sclerosis; there is currently no cure for the disease. Modern scientific understanding has considered multiple sclerosis (MS) to be a disease controlled by the … Continue Reading Specific subset of b-cell responsible for Multiple Sclerosis disease activity identified.
An innocent mistake made by a graduate student in a Northwestern Medicine lab (they accidentally used male mice instead of female mice during an experiment) has led scientists to an … Continue Reading Simple mistake made in study leads to sex bias breakthrough in multiple sclerosis.
In a report on what is believed to be the first small clinical trial of its kind, researchers at the Johns Hopkins Kimmel Cancer Center say they have safely used … Continue Reading Researchers safely use immune cells to treat multiple myeloma in human trials.
A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of … Continue Reading New treatment blocks progression of mutliple sclerosis in animal model.
A new study led by investigators at Brigham and Women’s Hospital (BWH) reports the discovery of a genetic variant that is associated with a patient’s likelihood of responding to interferon-beta, … Continue Reading New gene identified in multiple sclerosis disease activity.
Researchers identify how the blood-brain barrier is maintained to control ‘tight junction’ function.
It has long been known that the brain is protected from alterations elsewhere in the body by a highly regulated gateway known as the blood-brain barrier, which allows only selected … Continue Reading Researchers identify how the blood-brain barrier is maintained to control ‘tight junction’ function.
Scientists at the Centre for Addiction and Mental Health (CAMH) and the University of Toronto have discovered a promising new approach to treat multiple sclerosis (MS). In a new study, they’ve … Continue Reading New target identified in the spinal cord for multiple sclerosis.
Results from a preliminary study indicate that among patients with relapsing-remitting multiple sclerosis (MS), treatment with nonmyeloablative hematopoietic stem cell transplantation (low intensity stem cell transplantation) was associated with improvement … Continue Reading Stem cell transplant lessens brain lesions associated with Multiple Sclerosis in human trials.
One of the roadblocks to the eradication of tuberculosis (TB) is the difficulty in identifying patients with latent TB infections. Neither the tuberculin skin test nor interferon-gamma release assays (IGRAs) … Continue Reading New whole blood assay is the first to identify latent TB infections.